R F Suckow

457 total citations
8 papers, 343 citations indexed

About

R F Suckow is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, R F Suckow has authored 8 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in R F Suckow's work include Neuroscience and Neuropharmacology Research (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Treatment of Major Depression (2 papers). R F Suckow is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Treatment of Major Depression (2 papers). R F Suckow collaborates with scholars based in United States and Canada. R F Suckow's co-authors include Daniel C. Javitt, Thomas B. Cooper, Thomas M. Smith, A.S. Perumal, Nigel Bark, A.M. Shelley, Gail Silipo, Angel Cienfuegos, Stephen R. Zukin and Jean-Pierre Lindenmayer and has published in prestigious journals such as Biological Psychiatry, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

R F Suckow

8 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R F Suckow United States 5 215 106 92 92 59 8 343
Tatsuya Kotaka Japan 9 161 0.7× 138 1.3× 63 0.7× 69 0.8× 79 1.3× 13 328
Lin‐Whei Chuang United States 9 221 1.0× 112 1.1× 51 0.6× 36 0.4× 80 1.4× 11 410
Hans Kvande Sweden 10 218 1.0× 83 0.8× 30 0.3× 28 0.3× 34 0.6× 13 397
Chima Matsumoto Japan 13 101 0.5× 95 0.9× 59 0.6× 41 0.4× 129 2.2× 17 335
Jerry Oliver United States 10 135 0.6× 77 0.7× 50 0.5× 20 0.2× 136 2.3× 13 453
Bala Gulasekaram United States 4 102 0.5× 43 0.4× 75 0.8× 39 0.4× 259 4.4× 9 359
Jeffrey K Yao United States 7 102 0.5× 113 1.1× 166 1.8× 36 0.4× 116 2.0× 9 469
Ágnes Vass Israel 6 246 1.1× 154 1.5× 190 2.1× 218 2.4× 145 2.5× 17 566
Erin M. MacKenzie Canada 12 108 0.5× 122 1.2× 83 0.9× 42 0.5× 47 0.8× 26 411
B Heller Argentina 10 136 0.6× 87 0.8× 46 0.5× 59 0.6× 55 0.9× 19 334

Countries citing papers authored by R F Suckow

Since Specialization
Citations

This map shows the geographic impact of R F Suckow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R F Suckow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R F Suckow more than expected).

Fields of papers citing papers by R F Suckow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R F Suckow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R F Suckow. The network helps show where R F Suckow may publish in the future.

Co-authorship network of co-authors of R F Suckow

This figure shows the co-authorship network connecting the top 25 collaborators of R F Suckow. A scholar is included among the top collaborators of R F Suckow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R F Suckow. R F Suckow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Javitt, Daniel C., et al.. (2003). Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists. Neuropsychopharmacology. 29(2). 300–307. 83 indexed citations
2.
Javitt, Daniel C., Gail Silipo, Angel Cienfuegos, et al.. (2001). Adjunctive high-dose glycine in the treatment of schizophrenia. The International Journal of Neuropsychopharmacology. 4(4). 385–91. 155 indexed citations
3.
Malone, Kevin, et al.. (1997). Plasma tryptophan levels and prolactin response to fenfluramine in healthy volunteers. Biological Psychiatry. 42(5). 416–418. 2 indexed citations
4.
Pi, Edmond H., et al.. (1991). Saliva and plasma desipramine levels in Asian and Caucasian volunteers.. PubMed. 27(3). 281–4. 7 indexed citations
5.
McCue, Robert E., Anastasios Georgotas, R F Suckow, & Thomas B. Cooper. (1989). 10-Hydroxynortriptyline and treatment effects in elderly depressed patients. Journal of Neuropsychiatry. 1(2). 176–180. 3 indexed citations
6.
Suckow, R F, Thomas M. Smith, A.S. Perumal, & Thomas B. Cooper. (1986). Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.. Drug Metabolism and Disposition. 14(6). 692–697. 74 indexed citations
7.
Reches, Avinoam, S.E. Karpiak, Stanley Fahn, et al.. (1985). Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium. European Journal of Pharmacology. 113(2). 225–231. 2 indexed citations
8.
Barkai, A., R F Suckow, & T B Cooper. (1984). Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.. Journal of Pharmacology and Experimental Therapeutics. 230(2). 330–335. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026